Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ibrahim Etem Menarini (historically known as I.E. Ulagay) is a leading Turkish pharmaceutical company with a history dating back to 1903. Originally founded as a small medical analysis laboratory by Dr. Ibrahim Etem Ulagay, it grew to become Turkey's first pharmaceutical manufacturing company. In 2001, the Italian pharmaceutical giant Menarini Group acquired a majority stake in the company, forming Ibrahim Etem Menarini. Today, the company operates a state-of-the-art manufacturing facility in Istanbul, producing a wide range of primary care and specialist medicines, including antibiotics, cardiovascular drugs, and central nervous system treatments, serving both the domestic Turkish market and international export markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on I.E. Ulagay.